Cargando…
Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
Autores principales: | Carnero Contentti, Edgar, Correa, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131249/ https://www.ncbi.nlm.nih.gov/pubmed/32278860 http://dx.doi.org/10.1016/j.msard.2020.102097 |
Ejemplares similares
-
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
por: Carnero Contentti, Edgar, et al.
Publicado: (2021) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015) -
Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)